TuHURA Biosciences Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for TuHURA Biosciences, Inc. (HURA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Jun 2020Jun 2019Jun 2018
Operating Activities
Net Income-21.68-29.32-9.37-38.30-9.13-8.05-11.14
Depreciation & Amortization0.120.180.370.380.010.020.02
Stock Based Compensation1.960.480.220.650.000.000.00
Change in Working Capital3.290.491.56-0.490.151.130.58
Change in Accounts Payable3.640.341.850.000.000.000.00
Change in Other Working Capital1.280.15-0.290.630.000.000.00
Other Operating Activities1.280.01-0.290.631.040.030.01
Net Cash from Operating Activities-14.73-11.95-7.51-6.56-7.93-6.33-9.85
Investing Activities
Capital Expenditures-0.06-1.30-0.040.000.000.000.00
Acquisitions-5.99-1.220.000.970.000.000.00
Net Cash from Investing Activities-6.05-1.30-0.040.000.000.00-0.01
Financing Activities
Debt Repayment28.570.00-0.35-0.500.000.000.00
Common Stock Issued5.00-0.040.005.600.003.368.95
Common Stock Repurchased0.00-0.020.000.000.000.000.00
Dividends Paid0.000.010.010.010.01-0.01-0.01
Other Financing Activities-5.840.000.000.00-0.030.000.00
Net Cash from Financing Activities29.772.6616.257.046.604.079.25
Summary
Net Change in Cash8.99-10.598.710.48-1.33-2.25-0.61
Cash at Beginning of Period3.6714.255.555.073.725.976.59
Cash at End of Period12.663.6714.255.552.393.725.97
Free Cash Flow-14.79-13.25-7.54-6.57-7.93-6.33-9.86
Supplemental Disclosures
Interest Paid0.000.000.00-0.030.000.000.00